| scholarly article | Q13442814 |
| P2093 | author name string | Jie Lu | |
| Jeffrey I Zink | |||
| Fuyuhiko Tamanoi | |||
| Monty Liong | |||
| P2860 | cites work | Inhibition of gastric cancer by camptothecin involves apoptosis and multiple cellular pathways | Q33178791 |
| P433 | issue | 8 | |
| P921 | main subject | nanoparticle | Q61231 |
| hydrophobicity | Q41854968 | ||
| P304 | page(s) | 1341-1346 | |
| P577 | publication date | 2007-08-01 | |
| P1433 | published in | Small | Q3486838 |
| P1476 | title | Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs | |
| P478 | volume | 3 |
| Q33793138 | 25th anniversary article: interfacing nanoparticles and biology: new strategies for biomedicine |
| Q38809492 | 5-Azacytidine delivered by mesoporous silica nanoparticles regulates the differentiation of P19 cells into cardiomyocytes |
| Q64890354 | A Comparative Study of the Use of Mesoporous Carbon and Mesoporous Silica as Drug Carriers for Oral Delivery of the Water-Insoluble Drug Carvedilol. |
| Q28394647 | A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA |
| Q48270314 | A Peroxisome-Inspired Chemiluminescent Silica Nanodevice for the Intracellular Detection of Biomarkers and Its Application to Insulin-Sensitizer Screening |
| Q35967907 | A Review of Clinical Translation of Inorganic Nanoparticles. |
| Q92933598 | A Toolbox for the Synthesis of Multifunctionalized Mesoporous Silica Nanoparticles for Biomedical Applications |
| Q38931797 | A molecular nanocap activated by superparamagnetic heating for externally stimulated cargo release |
| Q57364172 | A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles |
| Q35009134 | A reversible light-operated nanovalve on mesoporous silica nanoparticles. |
| Q92350799 | Adsorption and Diffusion of Cisplatin Molecules in Nanoporous Materials: A Molecular Dynamics Study |
| Q36985900 | Advances and challenges of nanotechnology-based drug delivery systems. |
| Q59019210 | Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer |
| Q90663508 | An Assessment of Mesoporous Silica Nanoparticle Architectures as Antigen Carriers |
| Q45887696 | An Overview of Nanoparticle Based Delivery for Treatment of Inner Ear Disorders |
| Q50451301 | An efficient rose bengal based nanoplatform for photodynamic therapy. |
| Q34314945 | Antibody-functionalized porous silicon nanoparticles for vectorization of hydrophobic drugs |
| Q39204628 | Aptamer-based nanoparticles for cancer targeting |
| Q30501687 | Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. |
| Q37663672 | Bioabsorbable stent quo vadis: a case for nano-theranostics |
| Q34188389 | Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals |
| Q36161045 | Biocompatibility, endocytosis, and intracellular trafficking of mesoporous silica and polystyrene nanoparticles in ovarian cancer cells: effects of size and surface charge groups |
| Q89535281 | Biodegradable Periodic Mesoporous Organosilica (BPMO) Loaded with Daunorubicin: A Promising Nanoparticle-Based Anticancer Drug |
| Q42597124 | Bioresponsive mesoporous silica nanoparticles for triggered drug release |
| Q26829798 | Biosafe nanoscale pharmaceutical adjuvant materials |
| Q57296861 | Biostable, antidegradative and antimicrobial restorative systems based on host-biomaterials and microbial interactions |
| Q57183283 | Breast cancer cells imaging by targeting methionine transporters with gadolinium-based nanoprobe |
| Q39702119 | Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors |
| Q92671013 | Carboxymethyl Cellulose-Grafted Mesoporous Silica Hybrid Nanogels for Enhanced Cellular Uptake and Release of Curcumin |
| Q38924130 | Cell-penetrating peptide enhanced intracellular Raman imaging and photodynamic therapy. |
| Q60484411 | Cellular Internalization and Biocompatibility of Periodic Mesoporous Organosilica Nanoparticles with Tunable Morphologies: From Nanospheres to Nanowires |
| Q35921552 | Cellulose conjugated FITC-labelled mesoporous silica nanoparticles: intracellular accumulation and stimuli responsive doxorubicin release |
| Q57341098 | Ceramics for Drug Delivery |
| Q58147690 | Characterisation of silica nanoparticles prior to in vitro studies: from primary particles to agglomerates |
| Q38758605 | Chemistry of Mesoporous Organosilica in Nanotechnology: Molecularly Organic-Inorganic Hybridization into Frameworks. |
| Q34481521 | Chitosan-based intelligent theragnosis nanocomposites enable pH-sensitive drug release with MR-guided imaging for cancer therapy |
| Q45215886 | Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release |
| Q34618357 | Circumventing tumor resistance to chemotherapy by nanotechnology |
| Q33708231 | Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells |
| Q47726614 | Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment |
| Q57364652 | Coiled-coil peptide motifs as thermoresponsive valves for mesoporous silica nanoparticles |
| Q52588639 | Combinatorial approaches in post-polymerization modification for rational development of therapeutic delivery systems. |
| Q38898118 | Composition-property relationships in multifunctional hollow mesoporous carbon nanosystems for PH-responsive magnetic resonance imaging and on-demand drug release |
| Q43268015 | Controlled-access hollow mechanized silica nanocontainers |
| Q39245982 | Cucurbit[7]uril pseudorotaxane-based photoresponsive supramolecular nanovalve. |
| Q35797575 | Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells. |
| Q57376931 | Designed preparation of polyacrylic acid/calcium carbonate nanoparticles with high doxorubicin payload for liver cancer chemotherapy |
| Q38002853 | Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery |
| Q36328315 | Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy. |
| Q39363843 | Development of nanoaptamers using a mesoporous silica model labeled with (99m)tc for cancer targeting |
| Q43427418 | Disassembly-driven fluorescence turn-on of polymerized micelles by reductive stimuli in living cells |
| Q41197665 | Diseases originate and terminate by genes: unraveling nonviral gene delivery |
| Q38003964 | Docetaxel nanotechnology in anticancer therapy |
| Q26782780 | Drug Carrier for Photodynamic Cancer Therapy |
| Q37849730 | Drug delivery from structured porous inorganic materials |
| Q37845396 | Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis |
| Q51766226 | Drug delivery without nanoparticle uptake: delivery by a kiss-and-run mechanism on the cell membrane. |
| Q48223372 | Drug self-assembly for synthesis of highly-loaded antimicrobial drug-silica particles. |
| Q38739698 | Drug-loaded liposome-capped mesoporous core-shell magnetic nanoparticles for cellular toxicity study |
| Q39026102 | Effective delivery of volatile biocides employing mesoporous silicates for treating biofilms |
| Q42373834 | Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors |
| Q39378811 | Efficient intracellular delivery of camptothecin by silica/titania hollow nanoparticles |
| Q37300001 | Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery |
| Q55071436 | Emerging Therapeutic Potential of Nanoparticles in Pancreatic Cancer: A Systematic Review of Clinical Trials. |
| Q38875308 | Encapsulation of Anti-Tuberculosis Drugs within Mesoporous Silica and Intracellular Antibacterial Activities |
| Q39690268 | Encapsulation of water-insoluble drugs in polymer capsules prepared using mesoporous silica templates for intracellular drug delivery |
| Q37507270 | Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line |
| Q58120574 | Engineering molecular imaging strategies for regenerative medicine |
| Q38711119 | Engineering nanolayered particles for modular drug delivery. |
| Q33940884 | Enhanced gene and siRNA delivery by polycation-modified mesoporous silica nanoparticles loaded with chloroquine |
| Q39274627 | Enhanced in vitro antitumor efficacy and strong anti-cell-migration activity of a hydroxycamptothecin-encapsulated magnetic nanovehicle |
| Q46905081 | Enzyme-responsive silica mesoporous supports capped with azopyridinium salts for controlled delivery applications |
| Q43737005 | Enzyme-responsive snap-top covered silica nanocontainers |
| Q54324888 | Evaluation of cytotoxic, oxidative stress and genotoxic responses of hydroxyapatite nanoparticles on human blood cells. |
| Q90915689 | Exploring Factors for the Design of Nanoparticles as Drug Delivery Vectors |
| Q39466322 | FITC labeled silica nanoparticles as efficient cell tags: uptake and photostability study in endothelial cells. |
| Q57363798 | Fabrication of autofluorescent protein coated mesoporous silica nanoparticles for biological application |
| Q64936374 | Feasibility Study of Mesoporous Silica Particles for Pulmonary Drug Delivery: Therapeutic Treatment with Dexamethasone in a Mouse Model of Airway Inflammation. |
| Q57367156 | Fibrous-structured magnetic and mesoporous Fe3O4/silica microspheres: synthesis and intracellular doxorubicin delivery |
| Q39237999 | Folic acid-modified mesoporous silica nanoparticles for cellular and nuclear targeted drug delivery |
| Q99712128 | Formulation of Mesoporous Silica Nanoparticles for Controlled Release of Antimicrobials for Stone Preventive Conservation |
| Q64057777 | Functionalized Large-Pore Mesoporous Silica Microparticles for Gefitinib and Doxorubicin Codelivery |
| Q28387911 | Functionalized Nanoporous Silica for the Removal of Heavy Metals from Biological Systems: Adsorption and Application |
| Q36329186 | Functionalized self-assembled monolayers on mesoporous silica nanoparticles with high surface coverage |
| Q41679222 | Genotoxic effects of synthetic amorphous silica nanoparticles in the mouse lymphoma assay |
| Q84808182 | Getting physical to fix pharma |
| Q38730668 | Glucan particles for macrophage targeted delivery of nanoparticles |
| Q30353920 | Gold Nanosphere Gated Mesoporous Silica Nanoparticle Responsive to Near-Infrared Light and Redox Potential as a Theranostic Platform for Cancer Therapy. |
| Q57368926 | Gold nanorods-silica Janus nanoparticles for theranostics |
| Q34601136 | Harnessing a nanostructured fluorescence energy transfer sensor for quick detection of extremely small amounts of glucose. |
| Q47116787 | Highly lipophilic fluorescent dyes in nano-emulsions: towards bright non-leaking nano-droplets. |
| Q39296951 | Hollow superparamagnetic iron oxide nanoshells as a hydrophobic anticancer drug carrier: intracelluar pH-dependent drug release and enhanced cytotoxicity |
| Q38193109 | How physico-chemical characteristics of nanoparticles cause their toxicity: complex and unresolved interrelations |
| Q52726848 | Hyaluronic Acid Decorated Naringenin Nanoparticles: Appraisal of Chemopreventive and Curative Potential for Lung Cancer. |
| Q52582698 | Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer. |
| Q33993775 | Hydrogen peroxide sensors for cellular imaging based on horse radish peroxidase reconstituted on polymer-functionalized TiO₂ nanorods |
| Q39616099 | Hydrophilic mesoporous carbon nanoparticles as carriers for sustained release of hydrophobic anti-cancer drugs |
| Q58875459 | Improving pore exposure in mesoporous silica films for mechanized control of the pores |
| Q59017572 | In VitroEvaluation of Cytotoxicity of Colloidal Amorphous Silica Nanoparticles Designed for Drug Delivery on Human Cell Lines |
| Q88063108 | In vitro evaluation of the inhalable quercetin loaded nanoemulsion for pulmonary delivery |
| Q35566413 | In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification |
| Q33317126 | Inhibitors of protein geranylgeranyltransferase I and Rab geranylgeranyltransferase identified from a library of allenoate-derived compounds |
| Q38222448 | Inorganic nanomaterials for bioimaging, targeted drug delivery and therapeutics |
| Q38206112 | Integrated graphene/nanoparticle hybrids for biological and electronic applications. |
| Q39079389 | Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery |
| Q28390114 | Intracellular signal modulation by nanomaterials |
| Q37157022 | Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition. |
| Q33689859 | Iodinated oil-loaded, fluorescent mesoporous silica-coated iron oxide nanoparticles for magnetic resonance imaging/computed tomography/fluorescence trimodal imaging |
| Q36852611 | Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer |
| Q39093813 | Label-free luminescent mesoporous silica nanoparticles for imaging and drug delivery. |
| Q34273345 | Labeling and exocytosis of secretory compartments in RBL mastocytes by polystyrene and mesoporous silica nanoparticles |
| Q35099618 | Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery |
| Q35539266 | Laser beam controlled drug release from Ce6-gold nanorod composites in living cells: a FLIM study. |
| Q35685391 | Lectin-gated, mesoporous, photofunctionalized glyconanoparticles for glutathione-responsive drug delivery |
| Q37266438 | Light-activated nanoimpeller-controlled drug release in cancer cells |
| Q46153776 | Light-operated mechanized nanoparticles |
| Q58726168 | Lipid-Coated Mesoporous Silica Nanoparticles for the Delivery of the ML336 Antiviral to Inhibit Encephalitic Alphavirus Infection |
| Q53513254 | Magneto-plasmonic nanoparticles as theranostic platforms for magnetic resonance imaging, drug delivery and NIR hyperthermia applications. |
| Q33438675 | Measurement of fluorescence in a rhodamine-123 doped self-assembled "giant" mesostructured silica sphere using a smartphone as optical hardware |
| Q37774267 | Mechanised nanoparticles for drug delivery |
| Q58875428 | Mechanized Silica Nanoparticles Based on Pillar[5]arenes for On-Command Cargo Release |
| Q35387777 | Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine |
| Q64251805 | Mesoporous Silica Nanomaterials: Versatile Nanocarriers for Cancer Theranostics and Drug and Gene Delivery |
| Q38296554 | Mesoporous Silica Nanoparticles Decorated with Carbosilane Dendrons as New Non-viral Oligonucleotide Delivery Carriers |
| Q38665073 | Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer |
| Q42646371 | Mesoporous Silica Nanoparticles for Cancer Therapy: Energy-Dependent Cellular Uptake and Delivery of Paclitaxel to Cancer Cells |
| Q47295411 | Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications |
| Q47846969 | Mesoporous carbon nanomaterials in drug delivery and biomedical application |
| Q51041358 | Mesoporous carbon nanoshells for high hydrophobic drug loading, multimodal optical imaging, controlled drug release, and synergistic therapy. |
| Q36103833 | Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden. |
| Q28384598 | Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility |
| Q34273356 | Mesoporous silica nanoparticles as a compound delivery system in zebrafish embryos |
| Q38105259 | Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery. |
| Q37895950 | Mesoporous silica nanoparticles as nanocarriers. |
| Q42410638 | Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells |
| Q55155032 | Mesoporous silica nanoparticles for drug and gene delivery. |
| Q37778327 | Mesoporous silica nanoparticles for intracellular controlled drug delivery. |
| Q37973069 | Mesoporous silica nanoparticles in biomedical applications |
| Q26799990 | Mesoporous silica nanoparticles in target drug delivery system: A review |
| Q37233323 | Mesoporous silica nanoparticles synthesized from liquid crystal display manufacturing extracts as a potential candidate for a drug delivery carrier: evaluation of their safety and biocompatibility |
| Q57365492 | Mesoporous silica nanoparticles: importance of surface modifications and its role in drug delivery |
| Q37989408 | Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery |
| Q45937521 | Mesoporous silica nanospheres decorated with CdS nanocrystals for enhanced photocatalytic and excellent antibacterial activities. |
| Q57364103 | Mesoporous silicananoparticles for the design of smart delivery nanodevices |
| Q37386737 | Mesostructured Silica for Optical Functionality, Nanomachines, and Drug Delivery |
| Q49385440 | Modeling of a Hybrid Langmuir Adsorption Isotherm for Describing Interactions Between Drug Molecules and Silica Surfaces. |
| Q81323562 | Molecular machines: nanoscale gadgets |
| Q50921061 | Multi-step encapsulation of chemotherapy and gene silencing agents in functionalized mesoporous silica nanoparticles. |
| Q37735009 | Multifunctional enveloped mesoporous silica nanoparticles for subcellular co-delivery of drug and therapeutic peptide |
| Q33407563 | Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery |
| Q57367398 | Multifunctional mesoporous silica nanocarriers for stimuli-responsive target delivery of anticancer drugs |
| Q37377524 | Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. |
| Q39119319 | Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles |
| Q38679309 | Nanomedicine for Treatment of Lung Cancer |
| Q37104463 | Nanoparticle mediated non-covalent drug delivery |
| Q59019514 | Nanoparticle-Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges |
| Q35644991 | Nanoparticle-based targeted drug delivery |
| Q39165934 | Nanoparticle-induced morphological transition of Bombyx mori nucleopolyhedrovirus: a novel method to treat silkworm grasserie disease |
| Q91607551 | Nanoparticle-mediated targeted drug delivery for breast cancer treatment |
| Q37612053 | Nanoparticles and the blood coagulation system. Part II: safety concerns |
| Q37734893 | Nanoparticles functionalised with reversible molecular and supramolecular switches |
| Q37684727 | Nanopediatrics: enabling personalized medicine for children |
| Q55363814 | Nanosilica-supported liposome (protocells) as a drug vehicle for cancer therapy. |
| Q24650444 | Nanotechnology, nanotoxicology, and neuroscience |
| Q26774177 | Nanotechnology-based inhalation treatments for lung cancer: state of the art |
| Q60306460 | Nanotechnology-enabled materials for hemostatic and anti-infection treatments in orthopedic surgery |
| Q37238624 | Nanovalve-controlled cargo release activated by plasmonic heating |
| Q38787353 | Near-IR photoactivation using mesoporous silica-coated NaYF4:Yb,Er/Tm upconversion nanoparticles |
| Q36602038 | Nitric oxide-releasing silica nanoparticle inhibition of ovarian cancer cell growth |
| Q58676878 | Noncovalent functionalization of mesoporous silica nanoparticles with amphiphilic peptides |
| Q39672199 | Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. |
| Q37084805 | On-line micro column preconcentration system based on amino bimodal mesoporous silica nanoparticles as a novel adsorbent for removal and speciation of chromium (III, VI) in environmental samples |
| Q41612637 | One step synthesis of gold-loaded radial mesoporous silica nanospheres and supported lipid bilayer functionalization: towards bio-multifunctional sensors |
| Q33731037 | Optical imaging-guided cancer therapy with fluorescent nanoparticles |
| Q37822183 | Ordered mesoporous silicates as matrices for controlled release of drugs |
| Q59059654 | Organic-Inorganic Hybrid Hollow Mesoporous Organosilica Nanoparticles for Efficient Ultrasound-Based Imaging and Controlled Drug Release |
| Q50986669 | Oxime ligation on the surface of mesoporous silica nanoparticles. |
| Q39911952 | Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging |
| Q37487102 | Peptide modified mesoporous silica nanocontainers. |
| Q50802540 | Physicochemical properties affect the synthesis, controlled delivery, degradation and pharmacokinetics of inorganic nanoporous materials. |
| Q64932309 | Pollen-Structured Gold Nanoclusters for X-ray Induced Photodynamic Therapy. |
| Q39027154 | Poly(methyl vinyl ether-alt-maleic acid)-functionalized porous silicon nanoparticles for enhanced stability and cellular internalization |
| Q55262524 | Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release. |
| Q37510528 | Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs |
| Q33773418 | Polymeric nanomedicine for cancer MR imaging and drug delivery |
| Q58031609 | Polyvalent Mesoporous Silica Nanoparticle-Aptamer Bioconjugates Target Breast Cancer Cells |
| Q38683033 | Porous Silicon Nanoparticle Delivery of Tandem Peptide Anti-Infectives for the Treatment of Pseudomonas aeruginosa Lung Infections |
| Q37113784 | Porous nanoparticle supported lipid bilayers (protocells) as delivery vehicles |
| Q45893126 | Preloading of Hydrophobic Anticancer Drug into Multifunctional Nanocarrier for Multimodal Imaging, NIR-Responsive Drug Release, and Synergistic Therapy |
| Q88739587 | Preparation of a mesoporous silica-based nano-vehicle for dual DOX/CPT pH-triggered delivery |
| Q36672748 | Preparation, characterization and application of star-shaped PCL/PEG micelles for the delivery of doxorubicin in the treatment of colon cancer |
| Q37058424 | Recent advances in nanooncology |
| Q38648525 | Recent advances in siRNA delivery |
| Q37624164 | Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy |
| Q30792182 | Redox-mediated dissolution of paramagnetic nanolids to achieve a smart theranostic system. |
| Q90362515 | Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery |
| Q34763969 | Renal interstitial fibrosis induced by high-dose mesoporous silica nanoparticles via the NF-κB signaling pathway |
| Q82646640 | Room-temperature metal-activator-free phosphorescence from mesoporous silica |
| Q40665162 | Self-Sealing Porous Silicon-Calcium Silicate Core-Shell Nanoparticles for Targeted siRNA Delivery to the Injured Brain. |
| Q34275000 | Self-assembled nanoscale coordination polymers with trigger release properties for effective anticancer therapy |
| Q46456840 | Self-assembling nanowires of an amphiphilic camptothecin prodrug derived from homologous derivative conjugation. |
| Q35546582 | SiO(2) Nanoparticles Induced Cytotoxicity by Oxidative Stress in Human Bronchial Epithelial Cell, Beas-2B. |
| Q36531517 | Silica Nanoparticles Effects on Blood Coagulation Proteins and Platelets |
| Q33839296 | Silica nanoparticle supported lipid bilayers for gene delivery. |
| Q34080775 | Silica nanoparticles as a delivery system for nucleic acid-based reagents |
| Q37151406 | Silica-based mesoporous nanoparticles for controlled drug delivery |
| Q57367659 | Silica-based multifunctional nanodelivery systems toward regenerative medicine |
| Q97094559 | Silica-based organic-inorganic hybrid nanoparticles and nanoconjugates for improved anticancer drug delivery |
| Q53078688 | Single molecule photobehavior of a chromophore interacting with silica-based nanomaterials. |
| Q38563960 | Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles |
| Q33946663 | Smart nanocontainers as depot media for feedback active coatings |
| Q61800975 | Sol-gel derived boehmite nanostructures is a versatile nanoplatform for biomedical applications |
| Q35897521 | Stimulus-responsive controlled release system by covalent immobilization of an enzyme into mesoporous silica nanoparticles |
| Q28071773 | Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses |
| Q41963396 | Surface PEGylation of Mesoporous Silica Nanorods (MSNR): Effect on loading, release, and delivery of mitoxantrone in hypoxic cancer cells. |
| Q39354128 | Surface functionalization of mesoporous silica nanoparticles controls loading and release behavior of mitoxantrone |
| Q98564378 | Synergistic co-delivery of diacid metabolite of norcantharidin and ABT-737 based on folate-modified lipid bilayer-coated mesoporous silica nanoparticle against hepatic carcinoma |
| Q57365190 | Synergy effects of magnetic silica nanostructures for drug delivery applications |
| Q36562731 | Synthesis and biological response of size-specific, monodisperse drug-silica nanoconjugates. |
| Q92534446 | Synthesis and characterization of mesoporous SBA-15 and SBA-16 as carriers to improve albendazole dissolution rate |
| Q54779716 | Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery. |
| Q57777377 | Synthesis of Hetero-Polymer Functionalized Nanocarriers by Combining Surface-Initiated ATRP and RAFT Polymerization |
| Q35162222 | Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells |
| Q37906636 | Synthesis, toxicology and potential of ordered mesoporous materials in nanomedicine. |
| Q35941391 | Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles |
| Q92258236 | The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery |
| Q43227900 | The biocompatibility of mesoporous silicates |
| Q53763485 | The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent. |
| Q28385555 | The nanosilica hazard: another variable entity |
| Q39135535 | The pH-controlled nanoparticles size of polydopamine for anti-cancer drug delivery |
| Q37338427 | Therapeutic nanomedicine for brain cancer |
| Q92975591 | Thiolated Chitosan Masked Polymeric Microspheres with Incorporated Mesocellular Silica Foam (MCF) for Intranasal Delivery of Paliperidone |
| Q45881456 | Toxicity assessment of hydroxyapatite nanoparticles in rat liver cell model in vitro |
| Q42045032 | Trapping and release of cargo molecules from a micro-stamped mesoporous thin film controlled by Poly(NIPAAm-co-AAm). |
| Q30462417 | Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics |
| Q37529131 | Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. |
| Q34674541 | VEGF₁₂₁-conjugated mesoporous silica nanoparticle: a tumor targeted drug delivery system. |
| Q43286441 | pH clock-operated mechanized nanoparticles |
| Q42924183 | pH-operated nanopistons on the surfaces of mesoporous silica nanoparticles. |
| Q34580400 | pH-responsive dual cargo delivery from mesoporous silica nanoparticles with a metal-latched nanogate. |
| Q33499390 | pH-responsive mechanised nanoparticles gated by semirotaxanes |
| Q44416420 | pH-responsive supramolecular nanovalves based on cucurbit[6]uril pseudorotaxanes |
| Q90374088 | rGO nanomaterial-mediated cancer targeting and photothermal therapy in a microfluidic co-culture platform |
| Q57348031 | tLyP-1-conjugated mesoporous silica nanoparticles for tumor targeting and penetrating hydrophobic drug delivery |
Search more.